Cargando…

Checkpoint Blockade Rescues the Repressive Effect of Histone Deacetylases Inhibitors on γδ T Cell Function

Histone deacetylases (HDAC) are one of the key epigenetic modifiers that control chromatin accessibility and gene expression. Their role in tumorigenesis is well established and HDAC inhibitors have emerged as an effective treatment modality. HDAC inhibitors have been investigated for their specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhat, Sajad A., Vedpathak, Disha Mohan, Chiplunkar, Shubhada V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060239/ https://www.ncbi.nlm.nih.gov/pubmed/30072989 http://dx.doi.org/10.3389/fimmu.2018.01615

Ejemplares similares

The Jekyll and Hyde story of IL17-Producing γδT Cells
por: Patil, Rushikesh S., et al.
Publicado: (2015)

Transcriptome Signature of Vγ9Vδ2 T Cells Treated With Phosphoantigens and Notch Inhibitor Reveals Interplay Between TCR and Notch Signaling Pathways
por: Madhok, Ayush, et al.
Publicado: (2021)

Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption
por: Phalke, Swati P., et al.
Publicado: (2015)

Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis
por: Schilderink, R., et al.
Publicado: (2013)

Erratum: Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis
por: Schilderink, R., et al.
Publicado: (2013)

Histone deacetylase 3 represses cholesterol efflux during CD4(+) T-cell activation
por: Wilfahrt, Drew, et al.
Publicado: (2021)

Regulatory Effects of Histone Deacetylase Inhibitors on Myeloid-Derived Suppressor Cells
por: Cui, Yudan, et al.
Publicado: (2021)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia-Inducible Factors
por: Chen, Shuyang, et al.
Publicado: (2011)

Epigenetic Regulation of Host Defense Peptide Synthesis: Synergy Between Histone Deacetylase Inhibitors and DNA/Histone Methyltransferase Inhibitors
por: Whitmore, Melanie A., et al.
Publicado: (2022)

Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses
por: Dar, Asif Amin, et al.
Publicado: (2014)

Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
por: Shi, Yingfeng, et al.
Publicado: (2022)

Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization
por: Zhou, Xun, et al.
Publicado: (2023)

Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis
por: Nijhuis, Lotte, et al.
Publicado: (2019)

Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy
por: Bartish, Margarita, et al.
Publicado: (2020)

The emerging role of histone deacetylase 1 in allergic diseases
por: Wang, Yongfang, et al.
Publicado: (2022)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells
por: Bhat, Jaydeep, et al.
Publicado: (2019)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Histone deacetylase 6’s function in viral infection, innate immunity, and disease: latest advances
por: Qu, Min, et al.
Publicado: (2023)

Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction
por: Burke, Brianna, et al.
Publicado: (2020)

Sox9 represses gene expression via histone deacetylase activity
por: Tsuda, M, et al.
Publicado: (2003)

Histone deacetylase inhibitors induce medulloblastoma cell death independent of HDACs recruited in REST repression complexes
por: Alshawli, Abdulelah S., et al.
Publicado: (2020)

Dendritic cell development requires histone deacetylase activity
por: Chauvistré, Heike, et al.
Publicado: (2014)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
por: Muro, Ryunosuke, et al.
Publicado: (2023)

PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells
por: Stecher, Carmen, et al.
Publicado: (2017)

The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
por: Ren, Sijia, et al.
Publicado: (2021)

Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract
por: Dougan, Michael
Publicado: (2017)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
por: Petitprez, Florent, et al.
Publicado: (2020)

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
por: Peranzoni, Elisa, et al.
Publicado: (2020)

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
por: Zhang, Na, et al.
Publicado: (2020)

Histone deacetylase inhibitors in multiple myeloma
por: Deleu, Sarah, et al.
Publicado: (2009)

Histone deacetylase inhibitors in Hodgkin lymphoma
por: Buglio, Daniela, et al.
Publicado: (2010)

Clinical Toxicities of Histone Deacetylase Inhibitors
por: Subramanian, Srividya, et al.
Publicado: (2010)

Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006)

Histone Deacetylase Inhibitors as Anticancer Drugs
por: Eckschlager, Tomas, et al.
Publicado: (2017)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
por: Hassell, Kelly N.
Publicado: (2019)

Preferential differential gene expression within the WC1.1(+) γδ T cell compartment in cattle naturally infected with Mycobacterium bovis
por: Bhat, Sajad A., et al.
Publicado: (2023)

The Effect of Vicinal Difluorination on the Conformation and Potency of Histone Deacetylase Inhibitors
por: Ariawan, A. Daryl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4vfae2d3b0dqnejtu0p4ltcrs5